Predictors of progression in idiopathic inflammatory myopathies with interstitial lung disease

Abstract

The idiopathic inflammatory myopathies (IIMs) are a group of connective tissue diseases that afect multiple organ systems, including the lungs. Interstitial lung disease (ILD) is the most common and heterogeneous complication of IIMs, with its degree ranging from mild to fatal. Thus, it is critical to identify clinical features and validated biomarkers for predicting disease progression and prognosis, which could be beneficial for therapy adjustment. In this review, we discuss predictors for rapid progression of IIM-ILD and propose guidance for disease monitoring and implications of therapy. Systematic screening of myositis-specific antibodies, measuring serum biomarker levels, pulmonary function tests, and chest high-resolution computer tomography will be beneficial for the evaluation of disease progression and prognosis.

Prediction of acute kidney injury after cardiac surgery with fibrinogen-to-albumin ratio: a prospective observational study

“…Thus, it is crucial to identify clinical characteristics and validate biomarkers that can accurately predict patient prognosis. Achieving such breakthroughs would significantly increase the efficacy of screening and diagnostic tools ( 25 ).…”

“…The incidence of AKI may vary between studies due to factors such as variations in patient characteristics (e.g., age groups and types of surgery), differences in sample size, and different definitions of AKI. Several investigations have consistently recognized AKI as an element in prolonged hospitalization, a complicated clinical course, and increased mortality after cardiac surgery (24). However, it is a formidable task to detect and diagnose AKI at an early stage because it presents a wide range of clinical manifestations, spanning from the absence of symptoms to oliguria and potentially even renal failure.…”

Efficacy and safety of carrimycin in ten patients with severe pneumonia following solid organ transplantation

“…Therefore, conventional drugs typically have poor efficacy. When patients are infected, many inflammatory mediators and cytokines released during the inflammatory reaction cause acute lung injury, which can cause ARDS and even lead to systemic inflammatory response syndrome and MODS[ 40 ]. Although various treatment measures have been adopted, the condition of some patients cannot be effectively controlled.…”